News >

Treatment-Related AEs Can Require Careful Management in Patients With RCC

Caroline Seymour
Published: Wednesday, Jan 02, 2019

Heather Greene, NP
Heather Greene, NP
The treatment-related adverse events (TRAEs) associated with VEGF TKIs, mTOR inhibitors, and immunotherapy agents are easily managed more often than not in metastatic renal cell carcinoma (RCC), explained Heather Greene, NP.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication